Literature DB >> 29452403

Mechanisms controlling nucleic acid-sensing Toll-like receptors.

Kensuke Miyake1, Takuma Shibata1, Umeharu Ohto2, Toshiyuki Shimizu2, Shin-Ichiroh Saitoh1, Ryutaro Fukui1, Yusuke Murakami1.   

Abstract

Nucleic acid (NA)-sensing Toll-like receptors (TLRs) respond to DNA/RNA derived from pathogens and dead cells. Structural studies have revealed a variety of molecular mechanisms by which TLRs sense NAs. Double-stranded RNA and single-stranded DNA directly bind to TLR3 and TLR9, respectively, whereas TLR7 and TLR8 bind to nucleosides and oligoribonucleotides derived from RNAs. Activation of ligand-bound TLRs is influenced by the functional status of TLRs. Proteolytic cleavage of NA-sensing TLRs enables ligand-dependent TLR dimerization. Trafficking of ligand-activated TLRs in endosomal and lysosomal compartments is requisite for production of type I interferons. Activation of NA-sensing TLRs is required for the control of viruses such as herpes simplex virus and endogenous retroviruses. On the other hand, excessive activation of NA-sensing TLRs drives disease progression in a variety of inflammatory diseases including systemic lupus erythematosus, heart failure, arthritis and non-alcoholic steatohepatitis. NA-sensing TLRs are targets for therapeutic intervention in these diseases. We here focus on our recent progresses in our understanding of NA-sensing TLRs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29452403     DOI: 10.1093/intimm/dxy016

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  27 in total

Review 1.  Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs).

Authors:  Morgan Chandler; Morgan Brittany Johnson; Martin Panigaj; Kirill A Afonin
Journal:  Curr Opin Biotechnol       Date:  2019-11-25       Impact factor: 9.740

Review 2.  Macrophages play an essential role in trauma-induced sterile inflammation and tissue repair.

Authors:  Moritz Peiseler; Paul Kubes
Journal:  Eur J Trauma Emerg Surg       Date:  2018-04-17       Impact factor: 3.693

3.  Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.

Authors:  Elham Kalantari; Maryam Abolhasani; Raheleh Roudi; Mohammad M Farajollahi; Seif Farhad; Zahra Madjd; Shaghayegh Askarian-Amiri; Monireh Mohsenzadegan
Journal:  Int J Exp Pathol       Date:  2019-05-14       Impact factor: 1.925

Review 4.  Nucleic Acid Sensing by Toll-Like Receptors in the Endosomal Compartment.

Authors:  Kensuke Miyake; Takuma Shibata; Ryutaro Fukui; Ryota Sato; Shin-Ichiroh Saitoh; Yusuke Murakami
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  Control of IFN-I responses by the aminopeptidase IRAP in neonatal C57BL/6 alveolar macrophages during RSV infection.

Authors:  Carole Drajac; Daphné Laubreton; Quentin Marquant; Claire Chottin; Cécile Ferret; Edwige Bouguyon; Isabelle Schwartz-Cornil; Loredana Saveanu; Sabine Riffault; Delphyne Descamps
Journal:  Mucosal Immunol       Date:  2021-04-12       Impact factor: 7.313

Review 6.  Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies.

Authors:  Fan Tang; Yan Tie; Chongqi Tu; Xiawei Wei
Journal:  Clin Transl Med       Date:  2020-01

7.  Peroxisomes in host defense.

Authors:  Francesca Di Cara
Journal:  PLoS Pathog       Date:  2020-07-02       Impact factor: 6.823

Review 8.  RNase T2 in Inflammation and Cancer: Immunological and Biological Views.

Authors:  Lei Wu; Yanquan Xu; Huakan Zhao; Yongsheng Li
Journal:  Front Immunol       Date:  2020-08-13       Impact factor: 7.561

Review 9.  CD72 is a Negative Regulator of B Cell Responses to Nuclear Lupus Self-antigens and Development of Systemic Lupus Erythematosus.

Authors:  Takeshi Tsubata
Journal:  Immune Netw       Date:  2019-02-13       Impact factor: 6.303

10.  Cleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA.

Authors:  Ryutaro Fukui; Chikako Yamamoto; Fumi Matsumoto; Masahiro Onji; Takuma Shibata; Yusuke Murakami; Atsuo Kanno; Takuto Hayashi; Natsuko Tanimura; Nobuaki Yoshida; Kensuke Miyake
Journal:  Front Immunol       Date:  2018-06-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.